Skip to content

Sarepta Therapeutics, Inc. SRPT Other Working Capital

Other Working Capital at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$5.37M+324%
Insmed logo
InsmedINSM
$5.11M+1.8%
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
$6.59K+104%
uniQure logo
uniQureQURE
$242K-93.9%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$136K-77.9%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
-$8.8M-291%

Other financials

Income statement

See full
Revenue$730.8M-1.9%
Operating income-$300.4M-961%
Net income$331.0M+174%
EPS (diluted)-$4.60-1,343%

Balance sheet

See full
Cash & equivalents$464.5M+92.8%
Total debt$198.5M-3.4%
Total equity$1.5B+31.7%
Total assets$3.2B-8.3%

Cash flow

See full
Operating cash flow-$202.7M+65.3%
CapEx$2.1M-95.2%
Free cash flow-$204.8M+67.3%

Valuation

See full
Market cap$1.76B-63.1%

Profitability

See full
Operating margin-50.8%-1.6pp
Net margin4.6%+2.4pp
FCF margin-28.7%-9.2pp

Returns & leverage

See full
Return on equity-23.6%-28.5pp
Debt / equity0.1×0.0×
Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s other working capital?
Sarepta Therapeutics, Inc. (SRPT) reported other working capital of $1.29M in Q1 2026.
How has Sarepta Therapeutics, Inc.'s other working capital changed year-over-year?
Sarepta Therapeutics, Inc.'s other working capital increased by 394.1% year-over-year, from -$438K to $1.29M.
What does other working capital mean?
Net change in working capital items not separately classified — a residual balancing item.